LLY

826.35

+0.12%↑

UNH

549.29

-5.04%↓

JNJ

149.3

-0.15%↓

NVO

110.78

+1.8%↑

ABBV

176.22

+0.01%↑

LLY

826.35

+0.12%↑

UNH

549.29

-5.04%↓

JNJ

149.3

-0.15%↓

NVO

110.78

+1.8%↑

ABBV

176.22

+0.01%↑

LLY

826.35

+0.12%↑

UNH

549.29

-5.04%↓

JNJ

149.3

-0.15%↓

NVO

110.78

+1.8%↑

ABBV

176.22

+0.01%↑

LLY

826.35

+0.12%↑

UNH

549.29

-5.04%↓

JNJ

149.3

-0.15%↓

NVO

110.78

+1.8%↑

ABBV

176.22

+0.01%↑

LLY

826.35

+0.12%↑

UNH

549.29

-5.04%↓

JNJ

149.3

-0.15%↓

NVO

110.78

+1.8%↑

ABBV

176.22

+0.01%↑

Search

Accuray Inc

Closed

Sector Healthcare

2.01 5.24

Overview

Share price change

24h

Current

Min

1.88

Max

2.01

Key metrics

By Trading Economics

Income

-4M

Sales

-5.7M

102M

EPS

-0.04

Profit margin

-3.894

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+240.31 upside

Dividends

By Dow Jones

Next Earnings

29 Jan 2025

Market Stats

By TradingEconomics

Market Cap

1M

239M

Previous open

-3.23

Previous close

2.01

News Sentiment

By Acuity

22%

78%

57 / 392 Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

Accuray Inc Chart

Past performance is not a reliable indicator of future results.

Related News

5 Dec 2024, 23:57 UTC

Market Talk

Gold Edges Higher Ahead of U.S. Jobs Report -- Market Talk

5 Dec 2024, 23:54 UTC

Top News

Republicans Embrace DOGE on Capitol Hill -- Update

5 Dec 2024, 23:00 UTC

Top News

Anthem Backs Off Plans to Deny Anesthesia Claims After Public Backlash -- Barrons.com

5 Dec 2024, 22:26 UTC

Earnings

These Stocks Moved the Most Today: Tesla, MicroStrategy, Synopsys, SentinelOne, AeroVironment, American Airlines, Verint, and More -- Barrons.com

5 Dec 2024, 22:15 UTC

Top News

Anthem Backs Off Plans to Deny Anesthesia Claims After Public Backlash -- Barrons.com

5 Dec 2024, 22:11 UTC

Top News

Judge Rejects Boeing Guilty Plea Over DEI Requirement -- 3rd Update

5 Dec 2024, 22:02 UTC

Market Talk

Early November Figures Point to Torrid Home Sales in Canada -- Market Talk

5 Dec 2024, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

5 Dec 2024, 21:29 UTC

Acquisitions, Mergers, Takeovers

The Best-Performing GE Stock Keeps Getting New Buy Ratings -- Barrons.com

5 Dec 2024, 21:23 UTC

Earnings

Chevron: In Connection With Plans to Achieve $2B to $3B in Structural Cost Reductions by End 2026, Co Expects to Recognize Restructuring Chg of $0.7B to $0.9B After-Tax in 4Q >CVX

5 Dec 2024, 21:23 UTC

Earnings

Chevron: Two-Thirds Downstream Capex Allocated to U.S. Within Total Upstream and Downstream Budgets, $1.5B of Capex Dedicated to Lowering Carbon Intensity of Ops and Growing New Energies Businesses >CVX

5 Dec 2024, 21:23 UTC

Earnings

Chevron: Permian Basin Spend Is Lower Than 2024 Budget and Anticipated Between $4.5B and $5.0B as Production Growth Is Reduced in Favor of Free Cash Flow >CVX

5 Dec 2024, 21:23 UTC

Earnings

Chevron: Downstream Capex Is Expected Approximately $1.2B >CVX

5 Dec 2024, 21:23 UTC

Earnings

Chevron: Upstream Spending Is Expected to Be About $13B, of Which Roughly Two-Thirds Is Allocated to Develop U.S. Portfolio >CVX

5 Dec 2024, 21:20 UTC

Top News

Boeing's 737 MAX Plea Deal Rejected by Judge -- Barrons.com

5 Dec 2024, 21:19 UTC

Earnings

Chevron: Continue to Invest in High-Return, Lower-Carbon Projects That Position the Co to Deliver Free Cash Flow Growth >CVX

5 Dec 2024, 21:19 UTC

Earnings

Chevron: 2025 Capex and Affil Capex Budgets Represent a $2B Yr-over-Yr Reduction >CVX

5 Dec 2024, 21:19 UTC

Earnings

Chevron: Organic Cap Expenditure Range of $14.5B to $15.5B for Consolidated Subsidiaries and an Affil Cap Expenditure Range of $1.7B to $2.0B for 2025 >CVX

5 Dec 2024, 21:19 UTC

Earnings

Chevron: Restructuring and Other Charges Expected to Be $1.1B to $1.5B in 4Q >CVX

5 Dec 2024, 21:19 UTC

Earnings

Chevron: Announces 2025 Capex Budget & 4Q24 Interim Updates

5 Dec 2024, 21:17 UTC

Earnings

Toronto-Dominion Bank 4Q Rev C$15.51B >TD

5 Dec 2024, 21:17 UTC

Earnings

Toronto-Dominion Bank 4Q Net C$3.64B >TD

5 Dec 2024, 21:17 UTC

Earnings

Toronto-Dominion Bank 4Q Adj EPS C$1.72 >TD

5 Dec 2024, 21:17 UTC

Earnings

Toronto-Dominion Bank 4Q EPS C$1.97 >TD

5 Dec 2024, 21:15 UTC

Top News

Forget 'Drill, Baby, Drill.' Chevron Plans 'Cash, Baby, Cash.' -- Barrons.com

5 Dec 2024, 21:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

5 Dec 2024, 21:10 UTC

Market Talk
Earnings
Acquisitions, Mergers, Takeovers

Bank of Montreal Open to U.S. M&A, But Focus On ROE -- Market Talk

5 Dec 2024, 21:00 UTC

Market Talk

Global Equities Roundup: Market Talk

5 Dec 2024, 21:00 UTC

Market Talk

Gold Drops 1% as Market Waits for Jobs Report -- Market Talk

5 Dec 2024, 20:47 UTC

Top News

Republicans Embrace DOGE on Capitol Hill -- WSJ

Peer Comparison

Price change

Accuray Inc Forecast

Price Target

By TipRanks

240.31% upside

12 Months Forecast

Average 6.5 USD  240.31%

High 7 USD

Low 6 USD

Based on 2 Wall Street analysts offering 12 month price targets forAccuray Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

2

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

1.87 / 2.03Support & Resistance

Short Term

Bearish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Weak Bearish Evidence

Sentiment

By Acuity

57 / 392 Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Accuray Inc

Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports market-changing solutions that are designed to deliver radiation treatments. The Company's technologies include the CyberKnife and TomoTherapy platforms, including the Radixact System. The CyberKnife and TomoTherapy platform, which are designed to deliver treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT) and adaptive radiation therapy (ART). The CyberKnife Systems are robotic systems that are used to treat various types of cancer and tumors throughout the body. The CyberKnife Systems track, detect and correct for tumor and patient movement in real-time during the procedure. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.